Publications

Export 54 results:
In Press
Y. M. Ambrosini, Borcherding, D., Kanthasamy, A., Kim, H. Jung, Willette, A. A., Jergens, A., Allenspach, K., and Mochel, J. P., “The Gut-Brain-Axis in Neurodegenerative Diseases and Relevance of the Canine Model: A Review.”. In Press.
S. A.D., S., Z., E.M., P., Marti, M. E., S.K., M., and D.S., S., “Oriented growth and transdifferentiation of mesenchymal stem cells towards a Schwann cell fate on micropatterned substrates”, Journal of Bioscience and Bioengineering, In Press.
2019
K. BS†, C†, P., S, L., K, M. L., T, W., A, P., DW, R., Q, W., and AA, W., “Aging-related changes in fluid intelligence, muscle and adipose mass, and sex-specific immunologic mediation: A longitudinal UK Biobank study.”. 2019.
M. L. KE†, BE†, C., A, P., C, P., B, K., V, A., A;, K., and AA., W., “Is Cerebrospinal Fluid Superoxide Dismutase 1 a Biomarker of Tau But Not Amyloid-Induced Neurodegeneration in Alzheimer's Disease?”. 2019.
A. Plagman, Hoscheidt, S., McLimans, K. E., Klinedinst, B., Pappas, C., Anantharam, V., Kanthasamy, A., and Willette, A. A., “Cholecystokinin and Alzheimer's disease: a biomarker of metabolic function, neural integrity, and cognitive performance”. 2019.
J. Luo, Padhi, P., Jin, H., Anantharam, V., Zenitsky, G., Wang, Q., Willette, A. A., Kanthasamy, A., and Kanthasamy, A. G., “Utilization of the CRISPR-Cas9 Gene Editing System to Dissect Neuroinflammatory and Neuropharmacological Mechanisms in Parkinson’s Disease”, Journal of Neuroimmune Pharmacology, 2019.
2018
S. A, T, W., A, S., and AA, W., “Neuroinflammation in Alzheimer's disease: Pleiotropic roles for cytokines and neuronal pentraxins.”. 2018.
2017
J. Webb and Willette, A. A., “Aging Modifies the Effect of GCH1 RS11158026 on DAT Uptake and Parkinson's Disease Clinical Severity”. 2017.
K. E. McLimans and Willette, A. A., “Autotaxin is Related to Metabolic Dysfunction and Predicts Alzheimer’s Disease Outcomes”. 2017.
W. AA, JL, W., MW, L., BB, B., AM, W., JM, O., A, R., RL, K., BP, H., NM, D., S, A., and SC, J., “Family history and TOMM40 ‘523 interactive associations with memory in middle-aged and Alzheimer's disease cohorts”. 2017.
W. C.F. and V.G., C., Neuroscience of Pediatric PTSD. New York: Oxford University Press, 2017.
K. E. McLimans, JL, W., V, A., A, K., and AA, W., “Peripheral versus central index of metabolic dysfunction and associations with clinical and pathological outcomes in Alzheimer’s disease”. 2017.
W. C.F., “Severe stress and the development of the amygdala in youth: A theory and its statistical implications”, Developmental Review, 2017.
A. S. Bruce, S., A., ,, M., J., and Lusk, J., “A Simple Economic Conjecture of Neural Activations, Information Retrieval, and Discount Rates with an Application to fMRI”, Economics Working Papers, vol. 20, 2017.
2016
S. A† and AA†, W., “Alzheimer’s Disease Neuroimaging Initiative. Neuronal Pentraxin 2 predicts medial temporal atrophy and memory decline across the Alzheimer's disease spectrum”, Brain, Behavior, and Immunity, 2016.
W. AA, “Does metabolic syndrome impact cognition and emotion in Alzheimer's disease?”, European Journal of Neurology, 2016.
W. C.F., M., K., M., R., and V.G., C., “The moderating effects of sex on insula subdivision structure in youth with posttraumatic stress symptoms”, Depression and Anxiety, 2016.
J. L. Lusk, Crespi, J. M., McFadden, B. R., Cherry, J. B. C., Martin, L., and Bruce, A. S., “Neural Antecedents of a Random Utility Model.”, Journal of Economic Behavior & Organization, no. 132(A), pp. 93-103, 2016.
2015
A. A. Willette, Bendlin, B. B., Starks, E. J., Birdsill, A. C., Johnson, S. C., Christian, B. T., Okonkwo, O. C., La Rue, A., Hermann, B. P., Koscik, R. L., Jonaitis, E. M., Sager, M. A., and Asthana, S., “Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle–Aged Adults at Risk for Alzheimer Disease”, Journal of the American Medical Association Neurology , 2015.
W. AA, BB, B., EJ, S., AC, B., SC, J., BT, C., OC, O., A, L. Rue, BP, H., RL, K., EM, J., MA, S., and S, A., “Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.”, JAMA Neurology, 2015.
S. K. Mallapragada, Brenza, T. M., McMillan, J. E. M., Narasimhan, B., Sakaguchi, D. S., Sharma, A. D., Zbarska, S., and Gendelman, H. E., “Enabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicines”, Nanomedicine: NBM, vol. 11, no. 3, 2015.
P. N, H, S., H, J., M, N., DS, H., R, G., K, K., V, L., S, S., J, L., V, A., AG, K., and A, K., “Fyn Kinase Regulates Microglial Neuroinflammatory Responses in Cell Culture and Animal Models of Parkinson's Disease”, The Journal of Neuroscience, vol. 35, no. 27, 2015.
C. D, Y, Z., KE, L., R, P., and MB, R., “Green Tea Consumption Reduces Oxidative Stress in Parkinson’s Disease Patients”, Journal of Behavioral and Brain Science, vol. 5, no. 6, 2015.
A. D. Sharma, Brodski, P. A., Petersen, E. M., Dagdeviren, M., Ye, E., Mallapragada, S. K., and Sakaguchi, D. S., “High throughput characterization of adult stem cells engineered for delivery of therapeutic factors for neuroprotective strategies”, Journal of Visualized Experiments, no. 95, 2015.
W. AA, N, M., and D, K., “Insulin resistance predicts medial temporal hypermetabolism in mild cognitive impairment conversion to Alzheimer disease.”, Diabetes, 2015.
X. Che, He, Y., Yin, H., and Que, L., “A molecular beacon biosensor based on the nanostructured aluminum oxide surface”, Biosensors & Bioelectronics, vol. 72, 2015.
S. EL, DP, A., T, S., and CD, M. K., “Motor cortical oscillations are abnormally suppressed during repetitive movement in patients with Parkinson's disease.”, Clinical Neurophysiology, 2015.
J. M. Crespi, Lusk, J. L., J. Cherry, B. C., Martin, L. E., Mcfadden, B. R., and Bruce, A. S., “Neural Activations Associated with Decision-time and Choice in a Milk Labeling Experiment”, American Journal of Agriculture Economics, vol. 98, no. 1, 2015.
H. DS, H, J., V, A., A, K., and AG, K., “α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson's disease”, Toxicological Sciences, vol. 142, no. 2, 2015.
2014
S. EL, “Exploring a neuroplasticity model of music therapy”, Journal of Music Therapy , vol. 51, no. 3, 2014.
J. H, A, K., A, G., V, A., B, K., and AG, K., “Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes”, Biochimica et Biophysica Acta, vol. 1842, no. 8, 2014.
S. L. Solin, Wang, Y., Mauldin, J., Schultz, L., Lincow, D. E., Brodskiy, P. A., Jones, C. A., Syrkin-Nikolau, J., Linn, J. M., Essner, J. J., Hostetter, J. M., Whitley, E. M., Cameron, J. D., Chou, H. - H., Severin, A. J., Sakaguchi, D. S., and McGrail, M., “Molecular and cellular characterization of a zebrafish optic pathway tumor line implicates glia-derived progenitors in tumorigenesis”, PLoS One, vol. 9, no. 12, 2014.
J. Oh, Daniels, G. J., Chiou, L. S., Ye, E. - A., and Sakaguchi, D. S., “Multipotent adult hippocampal progenitor cells maintained as neurospheres favor differentiation toward glial lineages.”, Biotechnology Journal, vol. 9, no. 7, 2014.
G. HE, V, A., T, B., S, G., H, J., AG, K., X, L., J, M. M., RL, M., B, N., and SK, M., “Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases”, Nanomedicine: NBM, vol. 11, no. 3, 2014.
2012
G. A, A, K., J, J., V, A., P, S., BP, D., B, K., and AG, K., “Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease”, Journal of neuroinflammation, vol. 9, 2012.
A. L. Smiley-Oyen, Hall, S. A., Lowry, K. A., and Kerr, J. R., “Effects of extensive practice on bradykinesia in Parkinson's disease: improvement, retention and transfer”, Motor Control, vol. 16, no. 1, 2012.
T. Zhang, He, Y., Wei, J., and Que, L., “Nanostructured optical microchips for cancer biomarker detection”, Biosensors & Bioelectronics, vol. 38, no. 1, 2012.
2011
Z. Gong, Zhao, H., Zhang, T., Nie, F., Pathak, P., Cui, K., Wang, Z., Wong, S., and Que, L., “Drug effects analysis on cells using a high throughput microfluidic chip”, Biomedical Microdevices, vol. 13, no. 1, 2011.
A. Ngwa H, A, K., Y, G., N, F., V, A., and AG, K., “Manganese nanoparticle activates mitochondrial dependent apoptotic signaling and autophagy in dopaminergic neuronal cells”, Toxicology and Applied Pharmacology, vol. 256, no. 3, 2011.
X. Q, G, K., and MB, R., “Phytic Acid Protects against 6-Hydroxydopamine-Induced Dopaminergic Neuron Apoptosis in Normal and Iron Excess Conditions in a Cell Culture Model”, Parkinson's Disease, vol. 2011, no. 7, 2011.
P. Pathak, Zhao, H., Gong, Z., Zhang, T., Nie, F., Cui, K., Wang, Z., Wong, S., and Que, L., “Real-time monitoring of cell viability using direct electrical measurement with a patch-clamp microchip”, Biomedical Microdevices, vol. 13, no. 5, 2011.
J. H, A, K., A, G., Y, Y., V, A., and AG, K., “α-Synuclein negatively regulates protein kinase Cδ expression to suppress apoptosis in dopaminergic neurons by reducing p300 histone acetyltransferase activity”, The Journal of Neuroscience, vol. 31, no. 6, 2011.
2010
S. Penmetsa, Nagrajan, K., Gong, Z., Mills, D., and Que, L., “Biological cell controllable patch-clamp microchip”, Applied Physics Letters, vol. 97, no. 26, 2010.
S. C, A, K., V, A., and AG, K., “Environmental neurotoxic pesticide increases histone acetylation to promote apoptosis in dopaminergic neuronal cells: relevance to epigenetic mechanisms of neurodegeneration”, Molecular Pharmacology, vol. 77, no. 4, 2010.
S. C, A, K., V, A., and AG, K., “Environmental neurotoxic pesticide increases histone acetylation to promote apoptosis in dopaminergic neuronal cells: relevance to epigenetic mechanisms of neurodegeneration”, Molecular Pharmacology, vol. 77, no. 4, 2010.
K. A. Lowry, Carrel, A. J., J.M., M. I., and Smiley-Oyen, A. L., “Use of harmonic ratios to examine the effect of cueing strategies on gait stability in persons with Parkinson's disease”, Archives of Physical Medicine and Rehabilitation, vol. 91, no. 4, 2010.
2009
A. Ngwa H, A, K., V, A., C, S., T, W., R, H., and AG, K., “Vanadium induces dopaminergic neurotoxicity via protein kinase Cdelta dependent oxidative signaling mechanisms: relevance to etiopathogenesis of Parkinson's disease”, Toxicology and Applied Pharmacology, vol. 240, no. 2, 2009.
2008
A. L. Smiley-Oyen, Lowry, K. A., and Kerr, J. R., “Exercise, fitness, and neurocognitive function in older adults: the "selective improvement" and "cardiovascular fitness" hypotheses”, Annals of Behavioral Medicine, vol. 36, no. 3, 2008.
X. Q, G, K., and MB, R., “Neuroprotective effect of the natural iron chelator, phytic acid in a cell culture model of Parkinson’s disease ”, Toxicology, vol. 245, 2008.
A. V, A, K., CJ, C., DP, M., C, L., JA, R., and AG, K., “Opposing roles of prion protein in oxidative stress- and ER stress-induced apoptotic signaling”, Free Radical Biology & Medicine, vol. 45, no. 11, 2008.

Pages